Low-Dose Naltrexone: A New Frontier for Autoimmune Disease Relief
In recent years, the phrase low dose naltrexone (LDN) has been echoing through patient forums, integrative medicine circles, and even traditional clinical settings. Once known solely as a medication used in high doses to treat opioid or alcohol dependence, naltrexone has been rediscovered in a surprising way — as a potential modulator of the immune system. At just a fraction of its original dose, LDN is emerging as one of the most talked-about therapies for chronic inflammation and autoimmune diseases. The science is evolving quickly, and the evidence is beginning to support what many patients have long reported: low-dose naltrexone might help the body restore immune balance, reduce pain, and improve overall well-being. Let’s unpack what the latest science tells us — and what remains to be understood — about low-dose naltrexone for autoimmune disease . From Addiction Medicine to Immune Modulation Naltrexone was originally approved by the FDA in the 1980s at a dose of 50 mg d...